Antimicrobial resistance in Escherichia coli and Pseudomonas aeruginosa from Intensive Care Units in The Netherlands, 1998-2005

International Journal of Antimicrobial Agents

Volumn 31, Issue 1, 2008, Pages 58-63

  Oudhuis, G J ^a   Verbon, A ^a   Hoogkamp Korstanje, J A A ^a   Stobberingh, E E ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

lactam antibiotics; Aminoglycosides; Fluoroquinolones; Gram negative rods; Susceptibility

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CEFEPIME; CEFIXIME; CEFOTAXIME; CEFTAZIDIME; CEFTIBUTEN; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DILUTION; DRUG SURVEILLANCE PROGRAM; ESCHERICHIA COLI; HUMAN; INTENSIVE CARE UNIT; MINIMUM INHIBITORY CONCENTRATION; NETHERLANDS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ADULT; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; NETHERLANDS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SENTINEL SURVEILLANCE;

EID: 36849061203     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.08.009     Document Type: Article

References (15)

1. Jones M.E., Draghi D.C., Thornsberry C., Karlowsky J.A., Sahm D.F., and Wenzel R.P. Emerging resistance among bacterial pathogens in the intensive care unit-a European and North American Surveillance study (2000-2002). Ann Clin Microbiol Antimicrob 3 (2004) 14
2. Ibrahim E.H., Sherman G., Ward S., Fraser V.J., and Kollef M.H. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118 (2000) 146-155
3. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 5th ed. Approved standard M7-A5 (2002), NCCLS, Villanova, PA
4. Nys S., Okeke I.N., Kariuki S., Dinant G.J., Driessen C., and Stobberingh E.E. Antibiotic resistance of faecal Escherichia coli from healthy volunteers from eight developing countries. J Antimicrob Chemother 54 (2004) 952-955
5. Streit J.M., Jones R.N., Sader H.S., and Fritsche T.R. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Int J Antimicrob Agents 24 (2004) 111-118
6. Hanberger H., Diekema D., Fluit A., et al. Surveillance of antibiotic resistance in European ICUs. J Hosp Infect 48 (2001) 161-176
7. Yagupsky P. Selection of antibiotic-resistant pathogens in the community. Pediatr Infect Dis J 25 (2006) 974-976
8. Goossens H., Ferech M., Vander Stichele R., and Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365 (2005) 579-587
9. SWAB. NethMap 2007-consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in The Netherlands; 2007.
10. Cars O., Molstad S., and Melander A. Variation in antibiotic use in the European Union. Lancet 357 (2001) 1851-1853
11. Hanberger H., Erlandsson M., Burman L.G., et al. High antibiotic susceptibility among bacterial pathogens in Swedish ICUs. Report from a nation-wide surveillance program using TA90 as a novel index of susceptibility. Scand J Infect Dis 36 (2004) 24-30
12. Bergmans D.C., Bonten M.J., Gaillard C.A., et al. Indications for antibiotic use in ICU patients: a one-year prospective surveillance. J Antimicrob Chemother 39 (1997) 527-535
13. Filius P.M., Gyssens I.C., Kershof I.M., et al. Colonization and resistance dynamics of gram-negative bacteria in patients during and after hospitalization. Antimicrob Agents Chemother 49 (2005) 2879-2886
14. Sligl W., Taylor G., and Brindley P.G. Five years of nosocomial Gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes. Int J Infect Dis 10 (2006) 320-325
15. Hoogkamp-Korstanje J.A., and Roelofs-Willemse J. Antimicrobial resistance in Gram-negative bacteria from Intensive Care Units and Urology Services. A nationwide study in The Netherlands 1995-2000. Int J Antimicrob Agents 21 (2003) 547-556